Skip to content
Screener

Medtronic MDT Other operating segment — Net Sales

Other segment segments

Cardiovascular
$3.8B+13.8%
Neuroscience
$2.75B+5.0%
Medical Surgical
$2.39B+8.0%
Diabetes
$838M+15.1%
Other Operating Segments
$135M—

Similar metrics at other companies

Enerpac Tool Group logo
EPACOther Operating Segment — Net Sales
$6.59M+24.6%
Fastenal logo
FASTOther operating segment — Net Sales
$345.4M+8.5%
Scotts Miracle-Gro logo
SMGOther non-reportable operating segment — Net Sales
$82.5M+5.5%
Advanced Drainage Systems logo
WMSReportable Segment, Aggregation before Other Operating Segment — Net Sales
$557.32M-1.5%
Deckers Outdoor Corporation logo
DECKOther Brands Segment — Net Sales
$39.52M-35.6%
Mueller Water Products logo
MWAOther Operating Segment — Net Sales
$218.3M+1.0%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$109.3B-4.8%
Enterprise value$136.56B-4.0%
P/E22.8×-1.9×
P/S3×-0.4×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Medtronic’s 10-Q, filed February 24, 2026.

Filed
Feb 24, 2026, 4:18 PM EST
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-011107
(in millions)Worldwide / Three months ended / January 23, 2026Worldwide / Three months ended / January 24, 2025Worldwide / Nine months ended / January 23, 2026Worldwide / Nine months ended / January 24, 2025
Surgical & Endoscopy1,6541,5964,9454,790
Acute Care & Monitoring5194761,4831,406
Medical Surgical2,1732,0726,4286,196
Diabetes7966942,2742,027
Reportable segment net sales8,9858,26026,41724,593
Other operating segment(1)3232101106
Other adjustments(2)——39(90)
Total net sales$9,017$8,292$26,557$24,610

Item 1. Financial Statements

FAQ

What is Medtronic's other operating segment — net sales?
Medtronic (MDT) reported other operating segment — net sales of $32M in Q4 2025.
How has Medtronic's other operating segment — net sales changed year-over-year?
Medtronic's other operating segment — net sales decreased by 0.0% year-over-year, from $32M to $32M.
What is the long-term trend for Medtronic's other operating segment — net sales?
Over 3 years (2022 to 2025), Medtronic's other operating segment — net sales has grown at a -42.5% compound annual growth rate (CAGR), from $727M to $138M.
What does other operating segment — net sales mean?
This metric represents the total revenue generated by the company's secondary or non-core business segments that do not meet the quantitative thresholds for separate reporting. It reflects the aggregate sales performance of smaller product lines or emerging business units within the organization. Tracking this helps investors understand the contribution of diversified or experimental business activities to the overall top-line growth.

Ask your AI about Medtronic's other operating segment — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude